Ligand Pharmaceuticals reported $84.68M in Sales Revenues for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
Acceleron Pharma XLRN:US $ 24.76M 1.11M
Acorda Therapeutics ACOR:US $ 28.86M 9.3M
Agenus AGEN:US $ 11.72M 19.55M
Amgen AMGN:US $ 6526M 625M
Anika Therapeutics ANIK:US $ 34.29M 1.6M
Arena Pharmaceuticals ARNA:US $ 0M 0.04M
Arrowhead Research ARWR:US $ 32.81M 11.51M
Baxter International BAX:US $ 3098M 152M
Bristol Myers Squibb BMY:US $ 11703M 630M
Clovis Oncology CLVS:US $ 36.82M 1.23M
Dicerna Pharmaceuticals DRNA:US $ 47.6M 6.65M
Eli Lilly And LLY:US $ 6740.1M 65.5M
Enanta Pharmaceuticals ENTA:US $ 20.13M 11.61M
Endo International Ordinary Shares ENDP:US $ 717.92M 42.3M
Flexion Therapeutics FLXN:US $ 28.17M 3.59M
Gilead Sciences GILD:US $ 6217M 206M
GlaxoSmithKline GSK:LN 8092M 674M
Glaxosmithkline GSK:US $ 8092M 674M
Harsco HSC:US $ 569.82M 40.96M
Heron Therapeutics HRTX:US $ 20.02M 0.59M
Immunogen IMGN:US $ 16.95M 1.24M
Insmed INSM:US $ 40.21M 1.2M
Intrexon XON:US $ 24.51M 5.18M
IONIS PHARMACEUT IONS:US $ 125.75M 14.14M
Karyopharm Therapeutics KPTI:US $ 23.26M 11.84M
Lannett LCI:US $ 112.37M 21.55M
Ligand Pharmaceuticals LGND:US $ 84.68M 29.52M
Macrogenics MGNX:US $ 30.76M 13.88M
Merk MRK:US $ 11402M 678M
Pacira Pharmaceuticals PCRX:US $ 135.59M 16.56M
Pfizer PFE:US $ 18977M 4395M
Rigel Pharmaceuticals RIGL:US $ 26.27M 54.75M
Sangamo Biosciences SGMO:US $ 26.28M 0.48M
Spectrum Pharmaceuticals SPPI:US $ 0M 0M
Teva Pharmaceutical Industries TEVA:US $ 3910M 72M
Veracyte VCYT:US $ 55.1M 18.4M